Progress 07/01/24 to 06/30/25
Outputs Target Audience:During the reporting period the audience reached by the project and its results include the animal health scientific community, scientists and graduate students at Cornell. We have presented the results in scientific meetings such as the American Society for Virology Meeting (ASV) and the CRWAD meeting. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?This project has provided opportunity for training of 3 graduate students and 1 post-doctoral research associate. One of the PhD students has completed her PhD rsearch and is currently working on her thesis. She has started Vet School at Cornell, also as a result of her involvement with animals in this study. The other two PhD students are working on the characterization of host-factors on the persistence of SVA. How have the results been disseminated to communities of interest?We have presented the results from the project in national scientific conferences as well as in local graduate school presentations at Cornell. A manuscript was submitted for publication and is currently under review. A second manuscript is being drafted/edited and a PhD dissertation is being written and revised. What do you plan to do during the next reporting period to accomplish the goals?We plan to continue the characterization of host factors on SVA persistence in vitro We also plan to conduct an in vivo study with the recombinant SVA virus that is no longer able to establish persistence to determine what is the role of the 2C function on 3C on the ability of the virus to persist.
Impacts What was accomplished under these goals?
During the reporting period we made important strides in understanding the mechanisms underlying SVA persistence, using in vitro models of SVA persistent infection: To define virus-host cell interactions underlying establishment and maintenance of persistent SVA infection in vivo. By using in vitro cell culture models of SVA persistence including H1299, Pk15 and porcine tonsil cells we have demonstrated that SVA is capable of persisting for several days (up to 280) in H1299 and Pk15 cells witth cells constantly shedding virus in the supernatant of affected cells. We have shown using TUNEL and western blots that during persistence SVA inhibits host cell apoptosis. Additionally, by using bul RNAseq and single cell RNA seq in pi culture cells we identified a set of innate immune and prosurvival genes that are modulated during indection. We initiated to asses the role of a set of these host factors on SVA infection and replication in vitro. We have showed that the ISGs control SVA replication leading to reduced replication in cell culture in vitro. We are now investigating the steps of the infection cycle that are affected by 9 of these genes identified during the transcriptomic experiments. To characterize molecular determinants of SVA persistence. We have also investigated potential viral determinants of persistence. We have identified a unique function of SVA 2C protein which binds to SVA 3C protease and induces its degradation. Notably, 3C is a major inducer of host-cell apoptosis, a process that is inhibited by SVA during persistence. Using site-directed mutagenesis we have identifid a specific motif in 2C that is responsible for its activity in the 3C protease. Using site-directed mutagenesis we were able to demonstrate that by introducing a mutation on this site, SVA was cleared from the tonsil of infected animals suggesting that this function of 2C is important for SVA persistence in vivo. We plan to conduct additional studies using RNAseq and scRNAseq coupled with Spatial Transcriptomics to further characterize this function in establishment and maintenance of persistent infection. .
Publications
- Type:
Other Journal Articles
Status:
Under Review
Year Published:
2025
Citation:
Diaz, A.N., Ribeiro, L.C., Butt, S.L, Diel, D.G#. Stem loop I mutations in Senecavirus A 5 UTR reduce replication and virulence in pigs. Submitted, Frontiers and Cellular and Molecular Microbiology, July 7, 2025.
|
|